Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 81 results for "novartis"

Starting to design clinical studies in India: Novartis

Global drug major Novartis has invested, expanded its research development (RD) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio. Money Control, 2 weeks ago
Novartis India to consider Q3 and 9M results Business Standard, 1 month ago

881 images for novartis

Reuters, 13 hours ago
Money Control, 2 weeks ago
Ticker Report, 2 weeks ago
American Banking News, 2 weeks ago
Bio Spectrum Asia, 2 weeks ago
SleekMoney, 3 weeks ago
Sify, 3 weeks ago
Lets Recycle, 3 weeks ago
Yahoo! Finance UK and Ireland, 3 weeks ago
Yahoo! News, 3 weeks ago
Money Control

T-Hub inks MoU with Novartis Healthcare

T-Hub - a startup incubator set up by the Telangana Government today said it has signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
 Business Standard2 weeks ago T-Hub teams up with Novartis Healthcare to help health tech start-ups  Business Line2 weeks ago
catchnews.com

Sun Pharma buys skin cancer drug Odomzo for $175 mn from Novartis

Sun Pharmaceutical was approved by the US drug regulator in July 2015
 Business Standard2 months ago Sun Pharma gains after buying Novartis' cancer drug Odomzo  Business Standard2 months ago Sun Pharma to acquire cancer product Odomzo from Novartis for $175 million  catchnews.com2 months ago Sun Pharma acquires Novartis' oncology brand Odomzo for $175 mn  Business Standard2 months ago
[x]  

Sun Pharma to acquire Novartis’ cancer drug

An agreement has been signed between subsidiaries of both companies and the deal will close following anti-trust clearance and other closing conditions. Switzerland-based Novartis AG will get an additional milestone payment from Sun Pharma as per the deal ...
 The Hindu2 months ago

Top global pharma firms to participate in BioAsia 2017

Top global pharma firms including Johnson & Johnson, Novartis and GSK have confirmed participation in 14th BioAsia, scheduled to be held here from February 6, officials said.Organized by the Telangana government, the three-day event will bring together ...
 Prokerala1 month ago
Sify

European blue chip stocks offer great income opportunities - Barron's

European blue-chip stocks Nestle, Royal Dutch Shell, Novartis and Unilever are expected to be among the best income-producing stocks of 2017, Barron's said in a report. Many European companies offering dividends finished in the red, hurt by the rise in the ...
 Reuters1 month ago
[x]  
Reuters

Novartis says buys Ziarco Group to expand skin care portfolio

Novartis is buying privately held drugmaker Ziarco Group for an undisclosed sum to gain access to its investigational eczema medicine, the Swiss pharmaceutical giant said on Friday. The acquisition adds UK-based Ziarco's once-daily oral H4 receptor ...
 Reuters2 months ago
Sify

UPDATE 1-Trump to meet Novartis CEO, other pharma bosses on Tuesday

U. S. President Donald Trump, who has accused drugmakers of "getting away with murder" on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday.
 DNA3 weeks ago Trump to meet Novartis CEO, other pharma bosses on Tuesday  Sify3 weeks ago Indian pharma's Trump fears  Rediff.com3 weeks ago
Sify

Trump meets with drugmakers, seeks lower prices, U.S. production

Trump met with the CEOs of Novartis AG, Merck & Co Inc, Johnson & Johnson, Celgene Corp, Eli Lilly & Co, Amgen Inc as well as the head of the industry's lobbying group, the Pharmaceutical Research and Manufacturers of America.
 DNA3 weeks ago Trump pushes drugmakers for lower prices, more U.S. production  Sify3 weeks ago

European markets open higher;Novartis, Santander report earnings

The pan-European Stoxx 600 was 0.65 percent higher with all sectors trading positive.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less